NEW YORK (GenomeWeb) – Verge Genomics, a startup developing machine learning technologies to apply genomics to drug discovery in neuroscience, said today that it has closed a $32 million Series A funding round.

Silicon Valley investment firm DFJ led the round, with participation from the WuXi AppTec's Corporate Venture Fund, the ALS Investment Fund, Agent Capital, and the OS Fund.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.